Li Y et al. (52) found CCS promoted the growth and migration of breast cancer cells by regulating ROS-mediated ERK1/2 activity.In leukemia, COX17 inhibition can increase the level of mitochondrial copper, thereby affecting methionine metabolism and DNA methylation, and reduce the activity of leukemia stem cells (53). Here, MAPK3 is linked to leukemia.